The cure of ageing: Vitamin D - Magic or myth?

Postgraduate Medical Journal

Volumn 86, Issue 1020, 2010, Pages 608-616

  Chu, Michael P ^a   Alagiakrishnan, Kannayiram ^a   Sadowski, Cheryl ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN;

ALZHEIMER DISEASE; BONE DENSITY; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COLORECTAL CANCER; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MEGADOSE; FALLING; FRACTURE; HAZARD RATIO; HIP FRACTURE; HUMAN; HYPERTENSION; NONHODGKIN LYMPHOMA; NONHUMAN; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; RISK REDUCTION; UPPER RESPIRATORY TRACT INFECTION; VITAMIN D DEFICIENCY; AGED; DRUG ADMINISTRATION; MIDDLE AGED; NEOPLASM; RESPIRATORY TRACT DISEASE;

ACCIDENTAL FALLS; AGED; CARDIOVASCULAR DISEASES; DEMENTIA; DEPRESSIVE DISORDER; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; HUMANS; MIDDLE AGED; NEOPLASMS; OSTEOPOROSIS; RESPIRATORY TRACT DISEASES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 78049517196     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2010.101121     Document Type: Review

References (94)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
2. Cherniak EP, Florez H, Roos BA, et al. Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 2008;12:366-73.
3. Prentice A, Gail GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008;88(Suppl):500S-6S.
4. Campbell FC, Xu H, El-Tanani M, et al. The yin and yang of vitamin D receptor (VDR) signalling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol 2010;79:1-9.
5. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands: endoreceptor ligands. Endocr Rev 2005;26:662-87.
6. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr 2004;80 (6 Suppl):1678S-88S.
7. Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest 1996;26:436-42. (Pubitemid 26226405)
8. El-Sonbaty MR, Abdul-Ghaffar N. Vitamin D deficiency in veiled Kuwaiti women. Eur J Clin Nutr 1996;50:315-18. (Pubitemid 26154719)
9. Brender E, Burke A, Glass RM. Vitamin D. JAMA 2005;294:2386.
10. Genuis SJ, Schwalfenberg GK, Hiltz MN, et al. Vitamin D status of clinical practice populations at higher latitudes: analysis and applications. Int J Environ Res Public Health 2009;6:151-73.
11. Adams JS, Lee G. Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 1997;127:203-6. (Pubitemid 27332538)
12. Marriott BM. Vitamin D supplementation: a word of caution. Ann Intern Med 1997;127:231-3.
13. Leu JP, Weiner A, Barzel US. Vitamin D toxicity: caveat emptor. Endocr Pract 2008;14:1188-90.
14. Brannon PM, Yetley EA, Bailey RL, et al. Overview of the conference "Vitamin D and Health in the 21st century: an Update". Am J Clin Nutr 2008;88:483S-90S.
15. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus Vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
16. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415-23. (Pubitemid 46556419)
17. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657-66. (Pubitemid 47285316)
18. Avenell A, Gillespie WJ, Gillespie LD, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005;(3):CD000227.
19. The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010;340:b5463.
20. Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med 2002;18:141-58.
21. Lang T, Koyama A, Li C, et al. Pelvic body composition measurements by quantitative computed tomography: association with recent hip fracture. Bone 2008;42:798-805.
22. Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007;92:2058-65.
23. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >=60 y. Am J Clin Nutr 2004;80:752-8. (Pubitemid 41115542)
24. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of Vitamin D: a meta-analysis of randomized controlled trials. BMJ 2009;339:b3692.
25. Jackson C, Gaugris S, Sen SS, et al. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. Q J Med 2007;100:185-92. (Pubitemid 47061686)
26. Smith H, Anderson F, Raphael H, et al. Effect of annual vitamin D on fracture risk in elderly men and women: a population-based, randomized, double-blinded, placebo-controlled trial. Rheumatology 2007;46:1852-7. (Pubitemid 350168304)
27. Sanders KM, Stuart AI, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815-22.
28. Grimes DS, Hindle E, Dyer T. Sunlight, cholesterol and coronary heart disease. Q J Med 1996;89:579-89. (Pubitemid 26278869)
29. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9. (Pubitemid 15009153)
30. Shepherd J, Cobbe SM, Ford I, et al; for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N EngI J Med 1995;333:1301-7.
31. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4 S). Lancet 1994;344:1383-9.
32. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-80. (Pubitemid 351831400)
33. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-19.
34. Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev 2006;64:479-86.
35. Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007;261:558-65. (Pubitemid 46835978)
36. Rueda S, Fernández-Fernández C, Romero F, et al. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008;18:151-4.
37. Hjeismesaeth J, Hofso D, Aasheim ET, et al. PTH, but not vitamin D, is assoc with metabolic syndrome in morbidly obese women and men; a cross-sectional study. Cardiovasc Diabetol 2009;8:7-15.
38. Hsia J, Heiss G, Ren H, et al; Women's Health Initiative Investigators. Calcium/ vitamin D supplementation and cardiovascular events. Circulation 2007;115:846-54.
39. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001;86:1633-7. (Pubitemid 32377290)
40. Pittas AG, Chung M, Trikalines T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-14.
41. Wang L, Manson JE, Song Y, et al. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-23.
42. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5. (Pubitemid 41103882)
43. Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 2003;417:77-80.
44. Driver JP, Foreman O, Mathieu C, et al. Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alphahydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normalcalcaemic diet. Clin Exp Immunol 2008;151:76-85.
45. Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006;29:722-4.
46. Pittas AG, Harris SS, Stark PC, et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007;30:980-6.
47. De Boer IH, Tinker LF, Connelly S, et al. Calcium plus Vitamin D supplementation and the risk of incident diabetes in WHI. Diabetes Care 2008;31:701-7.
48. Leikina E, Delanoe-Ayari H, Melikov K, et al. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 2005;6:995-1001. (Pubitemid 41486184)
49. Li-Ng M, Aloia JF, Pollack S, et al. A RCT of vitamin D3 supplementation for the prevention of symptomatic URTI. Epidemiol Infect 2009;137:1396-404.
50. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-dydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90.
51. Aloia JF, Talwar SA, Pollack S, et al. A randomized controlled trial of Vitamin D3 supplementation in African American women. Arch Intern Med 2005;165:1618-23. (Pubitemid 41124156)
52. Sapey E, Stockley RA. COPD exacerbations. Thorax 2006;61:250-8.
53. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol 2009;158:20-5.
54. Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 2008;87:385-90. (Pubitemid 351226075)
55. Kester MI, Scheltens P. Dementia: the bare essentials. Pract Neurol 2009;9:241-51.
56. Lee DM, Tajar A, Ulubaev A, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009;80:722-9.
57. Wilkins CH, Sheline YI, Roe CM, et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-40.
58. Annweiler C, Allali G, Allain P, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009;16:1083-9.
59. Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerbrovascular pathology in elders receiving home services. Neurology 2010;74:18-26.
60. Stumpf WE, Privette TH. Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology (Berl) 1989;97:285-94.
61. Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitami n D levels. The Tromsø study. J Neurol 2006;253:464-70. (Pubitemid 43965611)
62. Jorde R, Sneve M, Figenschau Y, et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008;264:599-609.
63. Giovannuci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-9.
64. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96.
65. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008;100:1581-91.
66. Freedman DM, Looker AC, Chang SC, et al. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594-602.
67. Kelly JL, Friedberg JW, Calvi LM, et al. Vitamin D and non-hodgkin lymphoma risk in adults: a review. Cancer Invest 2009;27:942-51.
68. Armstrong BK, Kricker A. Sun exposure and Non-Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:396-400.
69. Davis CD. Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr 2008;88:565S-9S.
70. Lips F. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Rev 2001;22:477-501.
71. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4-8.
72. Holick MF. The use and interpretation of assays for vitamin D and its metabolites. J Nutr 1990;120(Suppl 11):1464-9.
73. Binkley N, Krueger D. Evaluation and correction of low vitamin D status. Curr Osteoporos Rep 2008;6:95-9.
74. Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporosis Int 2000;11:553-5.
75. National osteoporosis Foundation. Clinician 's guide to the prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation, 2008.
76. Zerwekh JE. Blood biomarkers and vitamin D status. Am J Clin Nutr 2008;87:1087S-91S.
77. Bolland MJ, Bacon CJ, Horne AM, et al. Vitamin D insufficiency and health outcomes over 5 years in older women. Am J Clin Nutr 2010;91:82-9.
78. Maxwell JD. Seasonal variation in vitamin D. Proc Nutr Soc 1994;53:533-43.
79. Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med 2005;352:515-16.
80. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004;29:663-73.
81. Anon. Standing committee on the scientific evaluation of dietary reference intakes of calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press, 1999.
82. Bischoff- Ferrari HA, Willet WC, Wong JB, et al. Fracture prevention from vitamin D supplementation: a meta- analysis of randomized controlled trials. JAMA 2008;293:2257-64.
83. Murray TM. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. CMAJ 1996;155:935-9.
84. Kaufman JM, Devogelaer JP, Raeman F, et al. Prevention and treatment of postmenopausal osteoporosis. National Consensus of the "Belgian Bone Club". Clin Rheumatol 1997;16:343-5.
85. Meunier PJ, Delmas PD, Eastell R, et al. Diagnosis and Treatment of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 1999;21:1025-44. (Pubitemid 29326161)
86. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. 1999, Updated January 2003. http://www.nof.org (accessed 18 Jul 2005).
87. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003;9:544-64. [Erratum, Endocr Pract 2004;10:90].
88. Office of the Surgeon General. Bone health and osteoporosis: a report of the Surgeon General. Rockville, Md: Department of Health and Human Services, 2004:436.
89. Working Group of the Australian and New Zealand Bone and Mineral Society; Endocrine Society of Australia; Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005;182:281-5.
90. Maalouf G, Gannagé-Yared MH, Ezzedine J, et al. Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 2007;7:131-43. (Pubitemid 47249002)
91. Anon. Dietary supplement fact sheet: vitamin D. Office of Dietary Supplements, National Institutes of Health, 2009. http://dietary-supplements. info.nih.gov/ factsheets/vitamind.asp.
92. Anon. Vitamin D: recommendations and review status. Health Canada 1995, Update 2009. http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php.
93. Anon. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:25-54.
94. http://clinicaltrials.gov/ct2/results?term=vitamin+d (accessed 23 Jun 2010).